iAnthus Capital Holdings, Inc. (CNSX: IAN)
Health Care · Pharmaceuticals · CA
CA$0.01
-50.00% today · -66.7% 1Y
iAnthus Capital Holdings, Inc. (CNSX: IAN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $24.44M and employs 741 people.
Over the last twelve months the share price has lost 66.7%, trading between 0.01 and 0.02.
Tweenvest scores iAnthus Capital Holdings, Inc. across four factors: quality 32/100, value 64/100, growth 0/100. Its strongest factor is value.
IAN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.44M
- Revenue (TTM)
- $139.14M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -0.67
- 52-week high
- CA$0.02
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 6.97B
- Employees
- 741
- Next earnings
- —
About iAnthus Capital Holdings, Inc.
iAnthus Capital Holdings, Inc. is a U.S.-based cannabis enterprise that holds licenses for and actively manages cannabis cultivation, processing, and retail dispensary operations. Its diverse product portfolio encompasses both cannabis and cannabidiol (CBD) offerings. For cannabis, these include traditional biomass items like pre-rolls, various infused products such as edibles and topical creams, and a wide array of concentrates and vapeables, specifically live resins, waxes, oils, tinctures, and vape cartridges. The CBD line features topical creams, tinctures, and sprays, alongside a comprehensive range of beauty and skincare solutions, including lotions, haircare items, lip balms, and bath bombs. Beyond direct retail, the company also engages in wholesale distribution of its CBD product selection. Operationally, iAnthus maintains a significant presence, controlling or operating 32 retail dispensaries and 10 cultivation or processing facilities across eight states. Established in 2014, its corporate headquarters are located in New York, New York.
- ISIN
- CA45074T1021
- Founded
- 2014
- Listed since
- Sep 7, 2016
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| IRLAB Therapeutics AB (publ)OM: IRLAB A | $25.37M | Skr1.71 | -8.08% |
| Cilo Cybin Holdings LimitedJSE: CCC | $25.26M | R1.45 | -2.68% |
| MedRx Co., LtdTSE: 4586 | $25.10M | ¥58.00 | -1.69% |
| Yung Zip Chemical Ind. Co., Ltd.TPEX: 4102 | $24.91M | NT$18.80 | +1.90% |
| Orexo AB (publ)OM: ORX | $24.32M | Skr6.19 | -5.93% |
| Everest Organics LimitedBSE: 524790 | $24.15M | Rs240.65 | +9.49% |
| Gennex Laboratories LimitedBSE: 531739 | $24.12M | Rs9.61 | -1.94% |
| PT Indofarma TbkIDX: INAF | $23.91M | Rp— | — |
Figures last refreshed Oct 11, 2026.